Page last updated: 2024-10-31

nafamostat and Foreign-Body Reaction

nafamostat has been researched along with Foreign-Body Reaction in 1 studies

nafamostat: inhibitor of trypsin, plasmin, pancreatic kallikrein, plasma kallikrein & thrombin; strongly inhibits esterolytic activities of C1r & C1 esterase complement-mediated hemolysis; antineoplastic

Foreign-Body Reaction: Chronic inflammation and granuloma formation around irritating foreign bodies.

Research Excerpts

ExcerptRelevanceReference
"Nafamostat mesilate may suppress the blood-foreign surface reaction similar to biocompatible materials by blocking factor XIIa."2.68Nafamostat mesilate reduces blood-foreign surface reactions similar to biocompatible materials. ( Hibi, M; Hiroura, M; Kawamura, M; Murakami, F; Murase, M; Ooshima, H; Tomita, Y; Usui, A; Yoshida, K, 1996)

Research

Studies (1)

TimeframeStudies, this research(%)All Research%
pre-19900 (0.00)18.7374
1990's1 (100.00)18.2507
2000's0 (0.00)29.6817
2010's0 (0.00)24.3611
2020's0 (0.00)2.80

Authors

AuthorsStudies
Usui, A1
Hiroura, M1
Kawamura, M1
Hibi, M1
Yoshida, K1
Murakami, F1
Tomita, Y1
Ooshima, H1
Murase, M1

Trials

1 trial available for nafamostat and Foreign-Body Reaction

ArticleYear
Nafamostat mesilate reduces blood-foreign surface reactions similar to biocompatible materials.
    The Annals of thoracic surgery, 1996, Volume: 62, Issue:5

    Topics: Benzamidines; Biocompatible Materials; Blood Coagulation Factors; Bradykinin; Cardiopulmonary Bypass

1996